Search
atovaquone/proguanil (Malarone)
Indications:
- treatment of chloroquine-resistant malaria, including Plasmodium falciparum & Plasmodium vivax
- prevention of malaria (chloroquine-resistant)
Dosage:
1) 1 tab/day starting 1-2 days before entering endemic area, continuing for 7 days after return
2) pediatric tablet is available for children
Related
malaria
General
pharmacologic combination
References
- Prescriber's Letter 7(8):46 2000
- Deprecated Reference
Components
atovaquone (Mepron)
proguanil (Chloroquanil, Bigumalum)